Abstract: A scrubbing solution for removing contaminants, including particularly hydrogen sulfide, from a fluid. The scrubbing solution includes at least one scrubbing reagent which has a primary or secondary amine and an acid, which may be phosphoric acid. The fluid being scrubbed is passed through the scrubbing solution. The contaminants react with the scrubbing reagent securing them in the scrubbing solution. The fluid being scrubbed and the scrubbing solution are then separated. The scrubbing solution is heated and, if the scrubbing solution is under pressure, the pressure is reduced. The acid facilitates thorough removal of the contaminants, and especially the hydrogen sulfide, from the scrubbing solution. The scrubbing solution is then ready for reuse. Because the scrubbing solution is rendered substantially free of hydrogen sulfides, it can absorb other sulfide contaminants that might not otherwise be absorbed.

Abstract: ABC multidrug transporters are key players in cancer multidrug resistance and in general xenobiotic elimination, thus their functional assays provide important tools for research and diagnostic applications. It has been found that in cells expressing functional ABCG2, ABCB1, or ABCC1 transporters, cellular PG fluorescence is strongly reduced. The invention relates to methods and uses of fluorescein derivative ester compounds of formula Ia which are analogs of PG for assessing ABC transporter activity of ABC multidrug transporters. The present accumulation assay is a novel tool for the parallel determination of the function of the multidrug transporters, in particular ABCG2, ABCB1, and ABCC1. The assay is applicable for diagnostic purposes and also allows the selection, separation and culturing of selected cell populations expressing such transporters.

Abstract: In an example, a method includes, at least one processor, in response to each of a plurality of requests, determining a halftone screen. Determining the halftone screen comprises encoding a signature pattern in the halftone screen, and halftone screens for different requests may be encoded with a different signature pattern. The halftone screen may be arranged such that, when applied to image data to provide a printed output, the pattern is discernible therein to provide a signature for the printed output.

Abstract: An apparatus for remote detection of plant growth dynamics is described. The apparatus includes an excitation LED (light emitting diode) module, a detection module and a controller module coupled to the excitation LED module and the detection module. The excitation LED module includes at least one LED. Each LED is configured to emit an excitation light in response to an excitation control signal. The excitation light has an emitted light spectrum. The detection module includes a photodetector configured to detect an initial chlorophyll a fluorescence (“ChlF”) light and an excited ChlF light from a plant species. The photodetector is further configured to convert the detected initial ChlF light into an initial detection electrical signal and the detected excited ChlF light into an excited detection electrical signal. The excited ChlF light is emitted from the plant species in response to receiving the excitation light.

Abstract: In particular embodiments, a sensitive data management system is configured to remove sensitive data after a period of non-use. Credentials used to access remote systems and/or third-party systems are stored with metadata that is updated with each use of the credentials. After a period of non-use, determined based on credential metadata, the credentials are deleted. Personal data retrieved to process a consumer request is stored with metadata that is updated with each use of the personal data. After a period of non-use, determined based on personal data metadata, the personal data is deleted. The personal data is also deleted if the system determines that the process or system that caused the personal data to be retrieved is no longer in use. An encrypted version of personal data may be stored for later use in verifying proper consumer request fulfillment.

Abstract: A blood treatment system with pressure sensors may be configured to control blood flow to and from the patient and use readings of the pressure sensors to determine a change in a pressure drop across a flow restriction in the blood circuit to estimate a condition of the machine or the patient, or outputting data responsive to the estimation. Further embodiments employ measurement of pressure drop to detect abnormal viscosity or viscosity variations in order to detect possible infection.

Abstract: A method for obtaining a culture supernatant form microalgae is provided, particularly wherein the culture supernatant is IMAC-enriched microalga culture supernatant and to an IMAC-enriched microalga culture supernatant obtained by the method of the invention. Also provided is a combination having a microalgal culture supernatant and a growth factor and to a cell culture media; a cosmetic composition and pharmaceutical composition and uses thereof.

Abstract: The disclosed subject matter relates to extracorporeal blood processing or other processing of fluids. Volumetric fluid balance, a required element of many such processes, may be achieved with multiple pumps or other proportioning or balancing devices which are to some extent independent of each other. This need may arise in treatments that involve multiple fluids. Safe and secure mechanisms to ensure fluid balance in such systems are described.

Abstract: A non-transitory computer-readable medium includes computer-executable instructions that, when executed, cause one or more processors of a first electronic device to perform operations including sending a request for asset data associated with an asset and receiving a set of telemetry data, a set of operational data, a set of inventory data, and a set of customer data associated with the asset. In the embodiment, the method includes selecting an asset model from a set of asset models associated with the asset based on the set of telemetry data, the set of operational data, the set of inventory data, and the set of customer data, wherein each asset model of the set of asset models corresponds to a particular task performed by the asset and generating a mapping hierarchy based on the selected asset model, wherein the mapping hierarchy includes a representation of a plant layout associated with the asset.

Abstract: An apparatus for cutting a wall of a vessel, such as scoring or slicing a lesion associated therewith. A catheter (10) includes a shaft (12) having a distal portion supporting a housing (20) including a first lateral passage (20a). A cutter (22) is adapted for moving from a retracted position within the housing (20) to a deployed position for at least partially projecting from the passage (20a). A expandable actuator (24) within the housing (20), such as an inflatable balloon (26), actuates the cutter (22) to move from the retracted position fully within the housing (20) to the deployed position at least partially projecting from the housing (20). More than one cutter (22?) may be provided, which cutters (22?) may be simultaneously actuated by the same actuator (26?).

Abstract: A non-transitory computer-readable medium may include computer-executable instructions that, when executed, cause a processor to collect a portion of data associated with an asset from one or more sources based on a request received from a digital representation associated with the asset. The digital representation may perform a first set of simulations related to one or more operations of the asset over time. The processor may then generate a plurality of aligned datasets based the portion of the data, the one or more sources, and an identity of the asset. The processor may also aggregate the plurality of aligned datasets into a single dataset and transmit the single dataset to the digital representation to perform a second set of simulations based on the single dataset.

Abstract: A nut blend for nut milk comprises a first nut base combinable with a second flavor base. The second flavor base (FB) can be selected from a composition consisting of one or more of a flavor profile/sweetener (V), a functional nutrition supplement (W) (i.e. superfood or adaptogen), and vitamins/minerals (X). In one exemplary arrangement, the flavor profile/sweetener (V) can comprise 30%-90% by weight of the flavor base; the nutrition supplement (W) can comprise 5%-65% by weight of the flavor base; and, the vitamins/minerals (X) can comprise 4%-10% by weight of the flavor base. The second flavor base can be packaged in a separate individual package or packet. The first nut base can be packaged in another separate individual package or packet. When desired, a selectable flavor base packet can be combined with a specified quantity or packet from a selectable nut base, according to user preferences.

Abstract: A vascular access device may include a blood circuit having an arterial blood line and a venous blood line. The venous blood line is connected to a first access needle and the arterial blood line is connected to a second access needle. The venous blood line is connected to an access component affixed to the second access needle and configured such that when the second access needle is used to infuse blood into a patient, the access component is positioned to withdraw blood and convey it into the venous line. The withdrawn blood may also be conveyed to an air detector to detect withdrawal of the second access needle.

Abstract: A blood treatment system with pressure sensors may be configured to control blood flow to and from the patient and use readings of the pressure sensors to determine a change in a pressure drop across a flow restriction in the blood circuit to estimate a condition of the machine or the patient, or outputting data responsive to the estimation. Further embodiments employ measurement of pressure drop to detect abnormal viscosity or viscosity variations in order to detect possible infection.

Abstract: A technique for performing time synchronization between a master device (200) and a slave device (210) is disclosed. A method implementation of the technique is performed by the master device (200) and comprises transmitting, using optical wireless signals, a timestamp representative of a clock time of the master device (200) to the slave device (210), wherein the timestamp is encoded using a color-based optical coding scheme and is to be used by the slave device (210) to set a clock time of the slave device (210) in accordance with the timestamp to thereby synchronize the clock time of the slave device (210) with the clock time of the master device (200).

Abstract: A co-polymer includes a plurality of a first monomer including a terminal functional group that is to attach to at least two different primers; a plurality of a second monomer including a second functional group that is different from the terminal functional group, and that is selected from the group consisting of a phenyl group, methoxy propyl, glycosyl, vinyl pyrrolidone, and an imidazole group; and a plurality of a third monomer that is different from the first and second monomers. This co-polymer may be used in a flow cell, and may enhance the clustering efficiency and kinetics.

Abstract: The disclosed subject matter relates to extracorporeal blood processing or other processing of fluids. Volumetric fluid balance, a required element of many such processes, may be achieved with multiple pumps or other proportioning or balancing devices which are to some extent independent of each other. This need may arise in treatments that involve multiple fluids. Safe and secure mechanisms to ensure fluid balance in such systems are described.

Abstract: A method for facilitating acquisition of a motor evoked potential (MEP) may include facilitating an MEP stimulation sequence to obtain the MEP. The facilitating may include delivering a first stimulation pulse to one or more peripheral nerves of a patient. The method may also include delivering, after the facilitating, the MEP stimulation sequence to one or more cranial nerves of the patient to obtain the MEP. The method may also include determining, based on the MEP, a physiological response has occurred. The method may also include indicating that the physiological response has occurred. The facilitating may reduce an intensity of the train of stimulation pulses of the MEP stimulation sequence, limit movement of the patient to the region of interest during the delivery of the MEP stimulation, and improve an accuracy of determining that the physiological response has occurred.

Abstract: A method for obtaining a culture supernatant form microalgae is provided, particularly wherein the culture supernatant is IMAC-enriched microalga culture supernatant and to an IMAC-enriched microalga culture supernatant obtained by the method of the invention. Also provided is a combination having a microalgal culture supernatant and a growth factor and to a cell culture media; a cosmetic composition and pharmaceutical composition and uses thereof.